Industry News

Companies To Collaborate on Gene-Based Therapeutics for Solid Tumors

Published in Gene Therapy Weekly, June 9th, 1997

Eli Lilly and Company, and Megabios Corp. announced that they have entered into a corporate collaboration to develop a gene-based therapeutic for certain solid tumors.

This transaction marks the first investment by Lilly in the field of gene-based therapeutics and the third major corporate collaboration for Megabios. The collaboration will focus on a single selected gene.

Megabios will be responsible for the development of lipid-based gene delivery systems for certain solid tumors and will share responsibility with Lilly for preclinical development. Lilly will be responsible for basic research, worldwide clinical development and regulatory...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1997-06-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry